In working with our providers and patients, our pharmacists recommend statin therapy for prevention of cardiovascular disease to improve patient outcomes and to deliver on performance measures.
SUPD/SPC
Patients 40 to 75 years of age with diabetes should be taking a moderate-intensity statin or maximally tolerated statin to lower the risk of ASCVD.*
Patients with established ASCVD should be taking a moderate- to high-intensity statin.**
ACSVD*** is one of the major causes of morbidity and mortality in the United States.
Statin use lowers the risk of ASCVD events and mortality.
It's time to address gaps in care.
Collaborative Efforts to Address SUPD and SPC:
We collaborate with the patient’s medical team to recommend therapy based on evidence-based guidelines and patient experiences. Through our dynamic, innovative approach and proven validation rates our clients continue to award higher volumes year over year.
Provide Patient Education
Address Barriers
Provider & Member Outreach
*ADA (American Diabetes Association) and ACC/AHA (American College of Cardiology/American Heart Association) guidelines
**ACC/AHA (American College of Cardiology/American Heart Association) guidelines
***Atherosclerotic Cardiovascular Disease